ENTRY       D10262                      Drug
NAME        Saxagliptin hydrochloride;
            Onglyza (TN)
PRODUCT     ONGLYZA (AstraZeneca Pharmaceuticals LP)
            ONGLYZA (Cardinal Health 107)
  GENERIC   SAXAGLIPTIN (Amneal Pharmaceuticals LLC)
            SAXAGLIPTIN (Aurobindo Pharma Limited)
            SAXAGLIPTIN (Glenmark Pharmaceuticals)
            SAXAGLIPTIN (Mylan Pharmaceuticals)
FORMULA     C18H25N3O2. HCl
EXACT_MASS  351.1714
MOL_WEIGHT  351.8709
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01601  DPP-4 inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      ATC code: A10BH03
            Chemical structure group: DG00119
            Product (DG00119): D09753<JP> D10262<US>
            Product (mixture): D10263<US> D10826<US>
EFFICACY    Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor
COMMENT     Treatment of type II diabetes mellitus and metabolic syndrome
TARGET      DPP4 (CD26) [HSA:1803] [KO:K01278]
  PATHWAY   hsa04974(1803)  Protein digestion and absorption
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
                 A10BH03 Saxagliptin
                  D10262  Saxagliptin hydrochloride &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
                Saxagliptin
                 D10262  Saxagliptin hydrochloride
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01601  DPP-4 inhibitor
                DG00119  Saxagliptin
                 D10262  Saxagliptin hydrochloride
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00119  Saxagliptin
                 D10262  Saxagliptin hydrochloride
              DG02925  CYP3A5 substrate
               DG00119  Saxagliptin
                D10262  Saxagliptin hydrochloride
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01601  DPP-4 inhibitor
               D10262  Saxagliptin hydrochloride
              DG02044  Hypoglycemic agent
               D10262  Saxagliptin hydrochloride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Peptidyl-peptidases
                DPP4 (CD26)
                 D10262  Saxagliptin hydrochloride &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10262
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10262
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10262
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10262
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01601  DPP-4 inhibitor
                DG00119  Saxagliptin
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00119  Saxagliptin
              DG02925  CYP3A5 substrate
               DG00119  Saxagliptin
DBLINKS     CAS: 709031-78-7
            PubChem: 163312293
ATOM        24
            1   C1z C    19.3200  -17.4300
            2   C1x C    18.6200  -18.8300
            3   C1y C    18.6200  -20.0900
            4   C1y C    18.1300  -19.3900
            5   C1z C    20.4400  -19.3900
            6   C1x C    17.0800  -20.5100
            7   C1x C    19.7400  -21.0700
            8   C1x C    18.1300  -18.0600
            9   C1x C    19.3200  -20.0200
            10  C1x C    20.4400  -18.0600
            11  C1c C    19.3200  -16.0300
            12  C5a C    20.5100  -15.4000
            13  N1a N    18.1300  -15.4000
            14  N1y N    21.7000  -16.0300
            15  O5a O    20.5100  -14.0000
            16  C1y C    22.1200  -17.3600
            17  C1y C    23.5200  -17.3600
            18  C1x C    23.9400  -15.9600
            19  C1y C    22.7500  -15.2600
            20  C3b C    22.7500  -13.8600
            21  N3a N    22.7500  -12.4600
            22  O1a O    21.7700  -19.3900
            23  C1x C    22.8200  -18.5500
            24  X   Cl   27.2300  -19.8100
BOND        27
            1     1   2 1
            2     2   3 1
            3     8   4 1
            4     4   9 1
            5     9   5 1
            6     5  10 1
            7    10   1 1
            8     1   8 1
            9     3   6 1
            10    3   7 1
            11    4   6 1
            12    5   7 1
            13    1  11 1
            14   11  12 1
            15   11  13 1 #Down
            16   12  14 1
            17   12  15 2
            18   14  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   14  19 1
            23   19  20 1 #Down
            24   20  21 3
            25    5  22 1
            26   17  23 1
            27   23  16 1
///
